Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Prevalence of Culture Negative Asitic Fluid Infection among Chronic Liver Disease Patients

View through CrossRef
Background and Aim: Ascitic fluid infection is pre-existing ascites infection of both symptomatic and asymptomatic types without abdominal source in chronic liver disease patients. Culture negative ascites are common infections in patients with chronic liver disease. The aim of the recent study was to determine the prevalence of culture-negative ascitic fluid infection among chronic liver disease patients. Methodology: This cross-sectional study was conducted on 134 patients with ascitic fluid infection due to chronic liver disease in the Department of Medicine and Gastroenterology, Pak International Medical College, Peshawar for six months duration from December 2020 to May 2021. All the ascitic infectious patients due to chronic liver disease regardless of their age and gender showing ascitic fluid infection symptoms such as tenderness, fever, and abdominal pain were admitted and underwent laboratory culture examination. Based on bacterial growth, all the chronic liver disease patients were grouped into two; Group-I of no bacterial growth and Group-II of positive bacterial growth. All the patients having an intra-abdominal infection or taking antibiotics were excluded. Results: Of the total 134 patients, 84 (62.7%) were male and 50 (37.3%) were females. Overall mean age was 47.56±19.8 years with an age range of 20 years to 80 years. Of the total 134 cases, the prevalence of positive and negative culture ascites were 30 (22.4%) and 104 (77.6%) respectively. out of 104 culture-negative patients, 65 (62.5%) were male patients whereas 39 (37.5%) were females. Chronic liver disease means duration was 8.9±2.6 months with a range of 6 months to 18 months. For all the patients above 40 years, the prevalence of culture-positive and negative ascitic infection was 20 (66.7%) and 77 (74.1%) respectively. The prevalence of male patients was higher (62.5%) among culture-negative patients due to chronic liver disease. Conclusion: Our study found that the prevalence of culture-negative ascitic fluid was higher at 77.6% among male patients. Also, ascitic fluid infection due to chronic liver disease was higher in patients of age above 40 years. Keywords: Ascitic fluid, Culture-negative ascitic fluid infections, Chronic liver disease
Title: Prevalence of Culture Negative Asitic Fluid Infection among Chronic Liver Disease Patients
Description:
Background and Aim: Ascitic fluid infection is pre-existing ascites infection of both symptomatic and asymptomatic types without abdominal source in chronic liver disease patients.
Culture negative ascites are common infections in patients with chronic liver disease.
The aim of the recent study was to determine the prevalence of culture-negative ascitic fluid infection among chronic liver disease patients.
Methodology: This cross-sectional study was conducted on 134 patients with ascitic fluid infection due to chronic liver disease in the Department of Medicine and Gastroenterology, Pak International Medical College, Peshawar for six months duration from December 2020 to May 2021.
All the ascitic infectious patients due to chronic liver disease regardless of their age and gender showing ascitic fluid infection symptoms such as tenderness, fever, and abdominal pain were admitted and underwent laboratory culture examination.
Based on bacterial growth, all the chronic liver disease patients were grouped into two; Group-I of no bacterial growth and Group-II of positive bacterial growth.
All the patients having an intra-abdominal infection or taking antibiotics were excluded.
Results: Of the total 134 patients, 84 (62.
7%) were male and 50 (37.
3%) were females.
Overall mean age was 47.
56±19.
8 years with an age range of 20 years to 80 years.
Of the total 134 cases, the prevalence of positive and negative culture ascites were 30 (22.
4%) and 104 (77.
6%) respectively.
out of 104 culture-negative patients, 65 (62.
5%) were male patients whereas 39 (37.
5%) were females.
Chronic liver disease means duration was 8.
9±2.
6 months with a range of 6 months to 18 months.
For all the patients above 40 years, the prevalence of culture-positive and negative ascitic infection was 20 (66.
7%) and 77 (74.
1%) respectively.
The prevalence of male patients was higher (62.
5%) among culture-negative patients due to chronic liver disease.
Conclusion: Our study found that the prevalence of culture-negative ascitic fluid was higher at 77.
6% among male patients.
Also, ascitic fluid infection due to chronic liver disease was higher in patients of age above 40 years.
Keywords: Ascitic fluid, Culture-negative ascitic fluid infections, Chronic liver disease.

Related Results

[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Abstract Introduction Fine-needle aspiration (FNA) is commonly used to investigate lymphadenopathy of suspected metastatic origin. The current study aims to find the association be...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Risk factors and severity of acute liver injury in non-chronic liver disease and chronic liver disease patients
Risk factors and severity of acute liver injury in non-chronic liver disease and chronic liver disease patients
Objectives To study factors related to acute liver injury and compare the severity and risk of those factors in patients with and without chronic liver disease. Methods This cross...

Back to Top